S-bio/Sumitomo Bakelite Co., Ltd.

We are S-bio team at Sumitomo Bakelite Co., Ltd.

[S-bio/Sumitomo Bakelite Co., Ltd. @S_bio_EN]

▼ For more details and registration, please visit:
https://t.co/aPgIMNm3px

[S-bio/Sumitomo Bakelite Co., Ltd. @S_bio_EN]

[Thursday, September 10th Global Webinar] Latest Trends in Organoid Manufacturing and Drug Discovery Research (English Presentation - Free Participation)

We regularly hold webinars to share the latest products and knowledge supporting drug discovery and regenerative medicine

[S-bio/Sumitomo Bakelite Co., Ltd. @S_bio_EN]

Latest knowledge on neural organoids (cerebral cortex, hippocampus, spinal cord, etc.)
Automation of organoid culture, mass production technology, high-throughput screening
Those engaged in pharmacokinetics research or in vitro toxicity evaluation (NAMs)

[S-bio/Sumitomo Bakelite Co., Ltd. @S_bio_EN]

we can use with confidence in cell pharmaceutical production.

- By Company S, a biopharmaceutical company in Japan

https://t.co/PrmelZd5Rz

[S-bio/Sumitomo Bakelite Co., Ltd. @S_bio_EN]

in the products has been reduced, and the status of pipette disposals has been significantly improved.
As a result, this has led to an increase in the yield of the final products. We feel that "SUMILON™ SuperQuality", manufactured under strict quality control, is a product

[S-bio/Sumitomo Bakelite Co., Ltd. @S_bio_EN]

☆Voice of Customer about SUMILON SuperQuality☆

With the previously used pipettes from other manufacturers, we experienced numerous disposals due to contamination by foreign substances. However, since switching to "SUMILON™ SuperQuality", contamination of foreign substances

[S-bio/Sumitomo Bakelite Co., Ltd. @S_bio_EN]

multiple organs, as well as the “PrimeSurface™ Series,” a 3D cell culture system capable of efficiently culturing uniform 3D cell spheroids. We look forward to seeing you there.

https://t.co/YabmLEeSLb

[S-bio/Sumitomo Bakelite Co., Ltd. @S_bio_EN]

☆Exhibition and Poster session at The 42nd Annual Meeting of The Japan Society of Drug Delivery System☆
We will be holding a corporate exhibition and poster session at the 42nd Annual Meeting of the Japanese Society for Drug Delivery Systems, to be held on July 30-31, 2026,

[S-bio/Sumitomo Bakelite Co., Ltd. @S_bio_EN]

drug delivery using MPS. Additionally, at our corporate exhibition booth (Booth No.12), we will showcase the “BioStellar™ Plate,” an on-chip pump-type multi-organ MPS system that provides a more realistic in vivo simulation environment by replicating interactions between

[S-bio/Sumitomo Bakelite Co., Ltd. @S_bio_EN]

human body, without relying on animal testing. We will announce details regarding our participation in the next exhibitions as soon as they are finalized. We sincerely look forward to seeing you there.

[S-bio/Sumitomo Bakelite Co., Ltd. @S_bio_EN]

☆Report on our Participation at Exhibition and Luncheon Seminar at the 53rd Annual Meeting of the Japanese Society of Toxicology☆

At the 53rd Annual Meeting of the Japanese Society of Toxicology (July 1–3), held at Grand Cube Osaka, we exhibited products related to our

[S-bio/Sumitomo Bakelite Co., Ltd. @S_bio_EN]

“3D cell culture” technologies. We will continue to be actively engaged  in information dissemination and exhibition activities to contribute to the promotion and development of next-generation technologies that enable the evaluation of drug safety under conditions closer to the